TNF microsatellites polymorphism is associated with rheumatoid arthritis. Confirming evidence in northwestern Colombians

Clinical and Experimental Rheumatology

Volumn 25, Issue 3, 2007, Pages 443-448

  Gomez, Luis M ^a,c   Ruiz Narváez, Edward A ^e   Pineda Tamayo, Ricardo ^b   Rojas Villarraga, Adriana ^b   Anaya, Juan Manuel ^a,d  

^a Corporación para Investigaciones Biológicas ^*  (Colombia)

^b Clinica Universitaria Bolivariana   (Colombia)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^d UNIVERSIDAD DEL ROSARIO   (Colombia)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genetic; HLA; Latin America; Microsatellites; Rheumatoid arthritis; TNF

Indexed keywords

CYTOKINE; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR 238G; TUMOR NECROSIS FACTOR 308G; TUMOR NECROSIS FACTOR A6; TUMOR NECROSIS FACTOR A7; TUMOR NECROSIS FACTOR A8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR B4; TUMOR NECROSIS FACTOR B7; TUMOR NECROSIS FACTOR C1; TUMOR NECROSIS FACTOR D4; TUMOR NECROSIS FACTOR E3; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CLINICAL FEATURE; COLOMBIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARTHRITIS, RHEUMATOID; COLOMBIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447626311     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. ANAYA JM, PINEDA-TAMAYO R, GOMEZ LM et al.: Artritis Reumatoide. Bases Moleculares, Clinicas y Terapeuticas. CIB, Medellin, Colombia, 2006.
2. SPINDLER A, BELLOMIO V, BERMAN A et al.: Prevalence of rheumatoid arthritis in Tucuman, Argentina. J Rheumatol 2002; 29: 1166-70.
3. DELGADO-VEGA AM, ANAYA JM: Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis. Autoimmun Rev 2006; 6: 402-8.
4. STASTNY P: Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976; 57: 1148-57.
5. WEYAND CM, HICOK KC, CONN DL, GORONZY JJ: The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992; 117: 801-6.
6. GREGERSEN PK, SILVER J, WINCHESTER RJ: The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-13.
7. FELDMANN M, BRENNAN FM, MAINI RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
8. HARAOUI B: Differentiating the efficacy of tumor necrosis factor inhibitors. J Rheumatol 2005; 74 (Suppl.): 3-7.
9. GRUEN, JR, WEISSMAN SM: Evolving views of the major histocompatibility complex. Blood 1997; 90: 4252-65.
10. HAJEER AH, HUTCHINSON IV: Influence of TNF alpha gene polymorphisms on TNF-alpha production and disease. Hum Immunol 2001; 62: 1191-9.
11. MARTINEZ A, FERNANDEZ-ARQUERO M, PASCUAL-SALCEDO D et al.: Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum 2000; 43: 1366-70.
12. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
13. BRAVO ML, VALENZUELA CY, ARCOS-BURGOS OM: Polymorphisms and phyletic relationships of the Paisa community from Antioquia [Colombia]. Gene Geogr 1996; 10: 11-7.
14. JIMENEZ I, MORA O, LOPEZ G et al.: Idiopathic epilepsy with generalized tonic clonic seizures in Antioquia, Colombia: Is the joint Amerindian and Negroid racial admixture the cause of its high prevalence? Biol Res 1996; 29: 297-304.
15. PARSONS JJ: Antioqueño colonization in western Colombia. In PARSONS JJ (Ed.): Title of Book, Please. Berkeley (CA), 1968.
16. ARCOS-BURGOS M, MUENKE M: Genetics of population isolates. Clin Genet 2002; 61: 233-47.
17. CARVAJAL-CARMONA LG, SOTO ID, PINEDA N et al.: Strong Amerind/ white sex bias and a possible Sephardic contribution among the founders of a population in northwest Colombia. Am J Hum Genet 2002; 67: 1287-95.
18. GALLAGHER G, ESKDALE J, OH HH, RICHARDS SD, CAMPBELL DA, FIELD M: Polymorphisms in the TNF gene cluster and MHC serotypes in the west of Scotland. Immunogenetics 1997; 45: 188-94.
19. UDALOVA IA, NEDOSPASOV SA, WEBB GC, CHAPLIN DD, TURETSKAYA RL: Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16: 180-6.
20. ANAYA JM, CORREA PA, MANTILLA RD, ARCOS-BURGOS M: Rheumatoid arthritis association in the Colombian population is restricted to HLA-DRB1*04 QRRAA alleles. Genes Immun 2002; 3: 56-8.
21. WEIR BS, HILL WG: Estimating F-statistics. Annu Rev Genet 2002; 36: 721-50.
22. CORREA PA, GOMEZ LM, CADENA J, ANAYA JM: Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 2005; 32: 219-24.
23. MATTEY DL, HASSELL AB, DAWES PT, OLLIER WE, HAJEER A: Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: Influence on disease outcome. Arthritis Rheum 1999; 42: 2698-704.
24. CASTRO F, ACEVEDO E, CIUSANI E, ANGULO JA, WOLLHEIM FA, SANDBERG-WOLLHEIM M: Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Ann Rheum Dis 2001; 60: 791-5.
25. MU H, CHEN JJ, JIANG Y, KING MC, THOMSON G, CRISWELL LA: Tumor necrosis factor α microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum 1999; 42: 438-42.
26. PASCUAL M, MATARAN L, JONES G et al.: HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes. Scand J Rheumatol 2002; 31: 275-8.
27. SINGAL DP, LI J, ZHU Y: HLA class III region and susceptibility to rheumatoid arthritis. Clin Exp Rheumatol 2000; 18: 485-91.
28. TAKEUCHI F, NABETA H, HONG GH et al.: The genetic contribution of the TNFa11 microsatellite allele and the TNFb + 252*2 allele in Japanese RA. Clin Exp Rheumatol 2005; 23: 494-8.
29. MATTEY DL, GONZALEZ-GAY MA, GARCIA-PORRUA C, THOMSON W, HAJEER AH, OLLIER WE: Influence of HLA-DRB1 and TNF microsatellite polymorphisms on the expression of extra-articular manifestations in rheumatoid arthritis patients from northwest Spain. Clin Exp Rheumatol 2001; 19: 703-8.
30. LYNN AH, KWOH CK, VENGLISH CM, ASTON CE. CHAKRAVARTI A: Genetic epidemiology of rheumatoid arthritis. Am J Hum Genet 1995; 57: 150-9.
31. MEYER JM, HAN J, S1NGH R, MOXLEY G: Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis. Am J Hum Genet 1996; 58: 371-83.
32. HAJEER A, JOHN S, OLLIER WE et al.: Tumor necrosis factor microsatellite haplotypes are different in male and female patients with RA. J Rheumatol 1997; 24: 217-9.
33. BRINKMAN BM, HUIZINGA TW, KURBAN SS et al.: Tumor necrosis factor alpha gene polymorphisms in rheumatoid arthritis: Association with susceptibility to, or severity of, disease? Br J Rheumatol 1997; 36: 516-21.
34. CVETKOVIC JT, WALLBERG-JONSSON S, STEGMAYR B, RANTAPAA-DAHLQVIST S, LEFVERT AK: Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. J Rheumatol 2002; 29: 212-9.
35. RODRIGUEZ-CARREON AA, ZUNIGA J, HERNANDEZ-PACHECO G et al.: Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun 2005; 24: 63-8.
36. VINASCO J, BERAUN Y, NIETO A et al.: Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997; 49:74-8.
37. WALDRON-LYNCH F, ADAMS C, AMOS C et al.: Tumor necrosis factor 5′ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families. Genes Immun 2001; 2: 82-7.
38. GUO SW, THOMPSON EA: Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48: 361-72.
39. CRAWFORD DC, AKEY DT, NICKERSON DA: The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet 2005; 6: 287-312.
40. FLAJNIK MF, KASAHARA M: Comparative genomics of the MHC: Glimpses into the evolution of the adaptive immune system. Immunity 2001; 15: 351-62.
41. MANLY KF: Reliability of statistical associations between genes and disease. Immunogenetics 2005; 57: 549-58.
42. MARTINEZ A, SALIDO M, BONILLA G et al.: Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients. Arthritis Rheum 2004; 50: 1077-82.
43. YEN JH, CHEN CJ, TSAI WC et al.: Tumor necrosis factor microsatellite alleles in patients with rheumatoid arthritis in Taiwan. Immunol Lett 2002; 81: 177-82.
44. GOMEZ LM, ANAYA JM, GONZALEZ CI et al.: PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun 2005; 6: 628-31.
45. SCHNEIDER S, KUEFFER JM, ROESSLI D, EXCOFFIER L: Arlequin. Genetic and Biometry Lab, Dept. of Anthropology, University of Geneva, Home Page at http://anthro.unige.ch/arlequin, 2000